A nanoparticle diagnostic for the detection and discrimination of human and avian influenza virus
Lead Research Organisation:
John Innes Centre
Department Name: Biological Chemistry
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Organisations
People |
ORCID iD |
Rob Field (Principal Investigator) |
Description | The market survey generated through this project has been used to underpin a BBSRC Follow-on Fund bid. |
Exploitation Route | The market survey generated through this project has been used to underpin a BBSRC Follow-on Fund bid. |
Sectors | Pharmaceuticals and Medical Biotechnology |
Description | The market survey generated through this project has been used to underpin a BBSRC Follow-on Fund bid. Subsequent to the above grant, the patent associated with tsi work was purchase by JIC-UEA spin-out Iceni Diagnostics (https://www.icenidiagnostics.com/), who are developing a farm-gate diagnostic for equine influenza. |
First Year Of Impact | 2019 |
Sector | Agriculture, Food and Drink,Healthcare,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology |
Impact Types | Societal Economic |
Company Name | Iceni Glycoscience |
Description | Iceni Glycoscience develops carbohydrate-based therapeutics and point-of-care diagnostics for infectious diseases using their own research in glycoscience, nanoparticle technology, and bioconjugation chemistry. |
Year Established | 2014 |
Impact | Too early |
Website | http://www.icenidiagnostics.com |